Patents by Inventor Xiaofang DENG

Xiaofang DENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230265183
    Abstract: Provided is an antibody molecule that binds to human Nectin-4 or a fragment thereof. The antibody is obtained by means of hybridoma screening and humanization techniques, and is used for the prevention or treatment of a cancer, and may be used as a clinical lead drug molecule.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 24, 2023
    Inventors: Hongyuan REN, Jian ZHU, Jian LIN, Lichun WANG, Xiaohong XU, Xiaofang DENG, Jianjun BI, Jin WANG, Jian WU
  • Publication number: 20230250168
    Abstract: Embodiments of the present disclosure provide an antibody that binds to human Claudin 18.2 or a fragment thereof, as well as encoded nucleic acids and the like thereof. The anti-human Claudin 18.2 antibody of embodiments of the present disclosure has strong affinity to an antigen Claudin 18.2 and significant complement-dependent cytotoxicity (CDC) activity and antibody-dependent cytotoxicity (ADCC) activity to target expression cells, and exhibits high specificity to human CLDN 18.2.
    Type: Application
    Filed: September 28, 2020
    Publication date: August 10, 2023
    Inventors: Jian LIN, Xiaofang DENG, Pan GAO, Xiaohong XU, Lichun WANG, Hongyuan REN, Jianjun BI, Jin WANG